Journals / Türk Kardiyoloji Derneği Arşivi / 2016 / Cilt: 44 - Sayı: 5

Cardiological and neurological implications in Fabry disease with noncompaction

Pages
450–451
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

FİNSTERER, J., STÖLLBERGER, C. (2022). Cardiological and neurological implications in Fabry disease with noncompaction. Türk Kardiyoloji Derneği Arşivi, Cilt: 44 - Sayı: 5, 450–451. https://ajindex.com/articles/632432

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Alper AT, Kaya A, Tekkesin Aİ, Öz A. Wolff-Parkinson-White and left ventricular noncompaction in a Fabry patient: A case report. Turk Kardiyol Dern Ars 2016;44:248-50.
  2. Martins E, Pinho T, Carpenter S, Leite S, Garcia R, Madureira A, et al. Histopathological evidence of Fabry disease in a female patient with left ventricular noncompaction. Rev Port Cardiol 2014;33:565.e1,6. Azevedo O, Gaspar P, Sá Miranda C, Cunha D, Medeiros R, Lourenço A. Left ventricular noncompaction in a patient with fabry disease: overdiagnosis, morphological manifestation of fabry disease or two unrelated rare conditions in the same patient? Cardiology 2011;119:155-9.
  3. Ortiz A, Abiose A, Bichet DG, Cabrera G, Charrow J, Germain DP, et al. Time to treatment benefit for adult patients with Fabry disease receiving agalsidase ?: data from the Fabry Registry. J Med Genet 2016.
  4. Frustaci A, Morgante E, Russo MA, Scopelliti F, Grande C, Verardo R, et al. Pathology and function of conduction tissue in Fabry disease cardiomyopathy. Circ Arrhythm Electrophysiol 2015;8:799-805.